Literature DB >> 9570799

Structural features determining differential receptor regulation of neuronal Ca channels.

A A Simen1, R J Miller.   

Abstract

Dihydropyridine-insensitive Ca channels are subject to direct receptor G-protein-mediated inhibition to differing extents. alpha1B channels are much more strongly modulated than alpha1E channels. To understand the structural basis for this difference, we have constructed and expressed various alpha1B and alpha1E chimeric Ca channels and examined their regulation by kappa-opioid receptors. Replacement of the first membrane-spanning domain of alpha1E with the corresponding region of alpha1B resulted in a chimeric Ca channel that was modulated by kappa-opioid receptors to a significantly greater extent than alpha1E. Transfer of the N terminus and I/II loop from alpha1B in addition to domain I resulted in a chimeric channel that was modulated to the same extent as alpha1B. Other regions of the molecule do not appear to contribute significantly to the degree of inhibition obtained, although the C terminus may contribute to facilitation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570799      PMCID: PMC6793165     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Whole-cell recording of calcium channel currents.

Authors:  B P Bean
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

Review 2.  Receptor-mediated regulation of calcium channels and neurotransmitter release.

Authors:  R J Miller
Journal:  FASEB J       Date:  1990-12       Impact factor: 5.191

3.  Molecular determinants of inactivation and G protein modulation in the intracellular loop connecting domains I and II of the calcium channel alpha1A subunit.

Authors:  S Herlitze; G H Hockerman; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Elementary events underlying voltage-dependent G-protein inhibition of N-type calcium channels.

Authors:  P G Patil; M de Leon; R R Reed; S Dubel; T P Snutch; D T Yue
Journal:  Biophys J       Date:  1996-11       Impact factor: 4.033

5.  Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction.

Authors:  R M Horton; Z L Cai; S N Ho; L R Pease
Journal:  Biotechniques       Date:  1990-05       Impact factor: 1.993

6.  A region of adenylyl cyclase 2 critical for regulation by G protein beta gamma subunits.

Authors:  J Chen; M DeVivo; J Dingus; A Harry; J Li; J Sui; D J Carty; J L Blank; J H Exton; R H Stoffel
Journal:  Science       Date:  1995-05-26       Impact factor: 47.728

7.  The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells.

Authors:  M Tallent; M A Dichter; G I Bell; T Reisine
Journal:  Neuroscience       Date:  1994-12       Impact factor: 3.590

8.  Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold.

Authors:  O Boussif; M A Zanta; J P Behr
Journal:  Gene Ther       Date:  1996-12       Impact factor: 5.250

9.  Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.

Authors:  P S Portoghese; A W Lipkowski; A E Takemori
Journal:  Life Sci       Date:  1987-03-30       Impact factor: 5.037

10.  kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system.

Authors:  F Simonin; C Gavériaux-Ruff; K Befort; H Matthes; B Lannes; G Micheletti; M G Mattéi; G Charron; B Bloch; B Kieffer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

View more
  17 in total

1.  Control of gating mode by a single amino acid residue in transmembrane segment IS3 of the N-type Ca2+ channel.

Authors:  H Zhong; B Li; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Identification of residues in the N terminus of alpha1B critical for inhibition of the voltage-dependent calcium channel by Gbeta gamma.

Authors:  C Cantí; K M Page; G J Stephens; A C Dolphin
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

3.  The C terminus of the Ca channel alpha1B subunit mediates selective inhibition by G-protein-coupled receptors.

Authors:  A A Simen; C C Lee; B B Simen; V P Bindokas; R J Miller
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

4.  G-protein inhibition of N- and P/Q-type calcium channels: distinctive elementary mechanisms and their functional impact.

Authors:  H M Colecraft; D L Brody; D T Yue
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

5.  Interaction between G proteins and accessory subunits in the regulation of 1B calcium channels in Xenopus oocytes.

Authors:  C Cantí; Y Bogdanov; A C Dolphin
Journal:  J Physiol       Date:  2000-09-15       Impact factor: 5.182

Review 6.  Neurotransmitter modulation of neuronal calcium channels.

Authors:  Keith S Elmslie
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 7.  Low-voltage-activated ("T-Type") calcium channels in review.

Authors:  Anne Marie R Yunker; Maureen W McEnery
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 8.  G protein modulation of CaV2 voltage-gated calcium channels.

Authors:  Kevin P M Currie
Journal:  Channels (Austin)       Date:  2010-11-01       Impact factor: 2.581

9.  Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons.

Authors:  S B Oh; P B Tran; S E Gillard; R W Hurley; D L Hammond; R J Miller
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

10.  Attenuation of G protein-mediated inhibition of N-type calcium currents by expression of caveolins in mammalian NG108-15 cells.

Authors:  M Toselli; V Taglietti; V Parente; S Flati; A Pavan; F Guzzi; M Parenti
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.